Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatory Issues in Prostate Cancer Studies.

Fourcroy1

  • 1Office of Health Affairs, Food and Drug Administration, Bethesda, Maryland.

Molecular Urology
|June 14, 2000
PubMed
Summary

Designing clinical trials requires careful consideration of quality of life and informed consent. Investigators must select appropriate measurement tools and distinguish between statistical and clinical significance for patient well-being.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Application of Pneumatic Chemistry to the Cure of Diseases.

The Medical and physical journal·2018
Same author

On the Urinary Stones and Gravel in Men.

The Medical and physical journal·2018
Same author

On the Urinary Stones and Calculi in Men.

The Medical and physical journal·2018
Same author

New Experiments on Mercurial Salts.

The Medical and physical journal·2018
Same author

Fourth International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer: Overview Consensus Statement.

Molecular urology·2000

Area of Science:

  • Clinical research design
  • Bioethics
  • Health outcomes research

Background:

  • Quality of life (QoL) is a critical factor in clinical trial design, encompassing physical, psychological, economic, and social dimensions.
  • Informed consent is a cornerstone of ethical research, ensuring participant autonomy and understanding.

Purpose of the Study:

  • To highlight key considerations for clinical trial designers regarding quality of life assessment and informed consent procedures.
  • To emphasize the distinction between statistical and clinical significance in evaluating trial outcomes.

Main Methods:

  • Review of established principles in clinical trial design.
  • Discussion of measurement instruments for assessing quality of life.
  • Examination of ethical guidelines for human subject protection.

Main Results:

  • Quality of life assessment requires careful selection of appropriate measurement tools tailored to study circumstances.
  • Identifying clinically significant changes is crucial, as statistical significance does not always equate to meaningful patient benefit.
  • Adherence to ethical guidelines and regulatory information is paramount for protecting human subjects.

Conclusions:

  • Effective clinical trial design necessitates a robust approach to measuring quality of life and ensuring truly informed consent.
  • Distinguishing clinical from statistical significance is vital for interpreting trial results and their impact on patients.
  • Understanding and complying with ethical and regulatory standards are essential for responsible clinical research.

Related Experiment Videos